期刊文献+

肿瘤细胞糖酵解途径的抗肿瘤研究 被引量:5

Anticancer based on glycolysis pathway in tumor cells
原文传递
导出
摘要 肿瘤细胞的葡萄糖代谢主要呈现出瓦博格效应(Warburg effect)。近年来,越来越多的实验证实基于肿瘤细胞有氧糖酵解途径的治疗可通过抑制多种分子、基因和信号途径限制能量供应,抑制肿瘤细胞增殖。这为肿瘤的靶向治疗提供了契机,具有巨大的潜在优势和广阔的临床应用前景。 Glucose metabolism of cancer ceils presents Warburg effect. In resent years, more and more experiments demonstrate that the therapeutics based on aerobic glycolysis pathway in cancer cells restrict energy and inhibit tumor proliferation through the inhibition of a Variety of moleculars, genes and signal pathways. These can provide an opportunity for targeted cancer therapies and possess enormous potential advantages and broad prospects in clinical application,
出处 《国际肿瘤学杂志》 CAS 2011年第12期914-916,共3页 Journal of International Oncology
关键词 肿瘤 糖酵解 治疗 Neoplasms Glycolysis Therapy
  • 相关文献

参考文献21

  • 1Fritz V, Fajas L. Metabolism and proliferation share common regulatory pathways in cancer ceils. Oneogene, 2010, 29(31) :4369-4-377.
  • 2Levine AJ, Puzio-Kuter AM. The control of the metabolic switch in cancers by oncogenes and tumor suppressor gene. Science, 2010, 330 ( 6009 ) : 1340-1344.
  • 3Gillies RJ, Robey I, Gatenby RA. Causes and consequences of increased g|ucose metabolism of cancers. J Nucl Med, 2008, 49 ( Suppl 2) :24S-42S.
  • 4Hempel N, Ye H, Abessi B, et al. Altered redox status accompanies progression to metastatic human bladder cancer. Free Radic Biol Med, 2009, 46( 1 ):42-50.
  • 5Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science, 2009, 324 (5930) : 1029-1033.
  • 6Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell, 2006, 9(6) :425-434.
  • 7Xu RH, Pelicano H, Zhou Y, et al. Inhibition of glycolysis in cancer Cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res, 2005, 65 (2) : 613-621.
  • 8Gottschalk S, Anderson N, Hainz C, et al. Imatinib (STI571 ) -mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells. Clin Cancer Res, 2004, 10 (19) : 6661-6668.
  • 9Can X, Fang L, Gibbs S, et al. Glucose uptake inhibitor sensitizes cancer cells to daunorub icin and overcomes drug resistance in bypoxia. Cancer Chemother Pharmacol, 2007, 59 (4) :495-505.
  • 10Ciuleanu TE, Pavlovsky AV, Bodoky G, et al. A randomised Phase III trial of glufosfamide compared with best supportive care in metastatic pancreatic adenocarcinoma previously treated with gemcitabine. Eur J Cancer, 2009, 45(9) :1589-1596.

同被引文献83

  • 1NEUMANN A K,YANG J,BIJU M P,et al.Hypoxia inducible factor Ⅰ alpha regulates T cell receptor signal transduction[J].Proc Natl Acad Sci USA,2005,102 (47):17071-17076.
  • 2WANG G L,SEMENZA G L.General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia[J].Proc Natl Acad Sci USA,1993,90(9):4304-4308.
  • 3CALLINAN L,MCCARTHY T V,MAULET Y,et al.Atypical L-type channels are down-regulated in hypoxia[J].Biochem Soc Trans,2005,33 (Pt5):1137-1139.
  • 4ELLARD J P,MCCUDDEN C R,TANEGA C,et al.The respiratory effects of stanniocalcin-1 (STC-1) on intact mitochondria and cells:STC-1 uncouples oxidative phosphorylation and its actions are modulated by nucleotide triphosphates[J].Mol Cell Endocrinol,2007,264 (1-2):90-101.
  • 5SHEIKH-HAMAD D,ROUSE D,YANG Y.Regulation of stanniocalcin in MDCK cells by hypertonicity and extracellular calcium[J].Am J Physiol Renal Physiol,2000,278 (3):F417-F424.
  • 6KANELLISJ,BICK R,GARCIA G,et al.Stanniocalcin-1,an inhibitor of macrophage chemotaxis and chemokinesis[J].Am J Physiol Renal Physiol,2004,286 (2):F356-F362.
  • 7ZHANG K Z,WESTBERG J A,PAETAU A,et al.High expression of stanniocalcin in differentiated brain neurons[J].Am J Pathol,1998,153 (2):439-445.
  • 8GILLIES R J,ROBEY I,GATENBY R A.Causes and consequences of increased glucose metabolism of cancers[J].J Nucl Med,2008,49 (Suppl 2):24S-42S.
  • 9SEMENZA G L.Defining the role of Hypoxiainducible factor 1 in cancer biology and therapeutics[J].Oncogene,2010,29(5):625-634.
  • 10HALESTRAP A P,PASDOIS P.The role of the mitochondrial permeability transition pore in heart disease[J].Biochim Biophys Acta,2009,1787 (11):1402-1415.

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部